- Home
- PYN vs COCH Comparison
PYN vs COCH Comparison
Compare PYN & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYN
- COCH
- Stock Information
- Founded
- PYN 2002
- COCH 1995
- Country
- PYN United States
- COCH United States
- Employees
- PYN N/A
- COCH N/A
- Industry
- PYN Investment Managers
- COCH Blank Checks
- Sector
- PYN Finance
- COCH Finance
- Exchange
- PYN Nasdaq
- COCH Nasdaq
- Market Cap
- PYN 30.1M
- COCH 31.6M
- IPO Year
- PYN N/A
- COCH N/A
- Fundamental
- Price
- PYN $5.09
- COCH $1.56
- Analyst Decision
- PYN
- COCH Strong Buy
- Analyst Count
- PYN 0
- COCH 2
- Target Price
- PYN N/A
- COCH $9.25
- AVG Volume (30 Days)
- PYN 19.9K
- COCH 27.9K
- Earning Date
- PYN 01-01-0001
- COCH 08-11-2025
- Dividend Yield
- PYN 5.07%
- COCH N/A
- EPS Growth
- PYN N/A
- COCH N/A
- EPS
- PYN N/A
- COCH N/A
- Revenue
- PYN N/A
- COCH $212,000.00
- Revenue This Year
- PYN N/A
- COCH $5.93
- Revenue Next Year
- PYN N/A
- COCH $17.69
- P/E Ratio
- PYN N/A
- COCH N/A
- Revenue Growth
- PYN N/A
- COCH N/A
- 52 Week Low
- PYN $4.84
- COCH $1.21
- 52 Week High
- PYN $6.60
- COCH $3.99
- Technical
- Relative Strength Index (RSI)
- PYN 35.88
- COCH 50.89
- Support Level
- PYN $5.05
- COCH $1.60
- Resistance Level
- PYN $5.12
- COCH $1.60
- Average True Range (ATR)
- PYN 0.06
- COCH 0.09
- MACD
- PYN -0.01
- COCH -0.01
- Stochastic Oscillator
- PYN 14.81
- COCH 32.47
About PYN PIMCO New York Municipal Income Fund III of Beneficial Interest
PIMCO New York Municipal Income Fund III is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State, and New York City income tax. To pursue the objectives, the fund invests a majority of its net assets in municipal bonds that pay interest that is exempt from federal, New York State, and New York City income tax.
About COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.